Investigational drug · Phase 3
poliomyelitis vaccine
Not approved by FDA. In 3 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Healthy Volunteers, Whooping Cough, Diphtheria.
Phase 3Last checked: Nov 20, 2026Latest source record: Jan 21, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 3
Industry-sponsored trials
Phase 2 and 3 trials
3
2 still active
All registered trials
319
Any phase or sponsor naming "poliomyelitis vaccine"
First trial start
2021
Oct 22, 2021
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "poliomyelitis vaccine", any sponsor or status.
Conditions studied
As listed on its trial records.
- Healthy Volunteers
- Whooping Cough
- Diphtheria
- Tetanus
- Meningococcal Immunisation
Largest trials
Live from ClinicalTrials.gov: studies naming "poliomyelitis vaccine" as an intervention, largest first.
Neuroganics LLCIndustry
NCT05095844 · 100,000 participants (planned) · Start Mar 15, 2022 · Primary completion Apr 1, 2024
Drug: vaccinated · For: COVID-19; Vaccine Adverse Reaction; Vaccine Reaction and 10 more
Sites: Northglenn, Colorado
Sanofi Pasteur, a Sanofi CompanySanofi (SNY)
NCT00804284 · 62,538 participants · Start Sep 2008 · Primary completion Aug 2014
Drug: DTaP-IPV/Hib; Other DTap Vaccines · For: Diphtheria; Tetanus; Pertussis and 1 more
Sites: Oakland, California
- To Develop, Implement and Evaluate the Polio Demonstration Project Comprising of a Community Based Intervention Package for Polio Eradication in PakistanPivotal-lookingStatus unknown
Aga Khan UniversityAcademic, hospital or other
NCT01908114 · 60,000 participants (planned) · Start Jul 2013 · Primary completion Jul 2017
Drug: Combined Oral Polio Vaccine and Inject able Polio Vaccine during SIA · For: Polio; Polio Sero Conversion; Polio Sero Prevalence and 1 more
Sites: Karachi, Pakistan
Institute of Medical Biology, Chinese Academy of Medical SciencesAcademic, hospital or other
NCT04220515 · 49,731 participants · Start Feb 8, 2018 · Primary completion Aug 8, 2019
Drug: Inactivated Poliomyelitis Vaccine Made From Sabin Strain · For: Poliomyelitis
Sites: Shanghai, China
- Vaccine Campaign Effects on General Hospital Admissions and Mortality Among ChildrenPivotal-lookingCompleted
Bandim Health ProjectAcademic, hospital or other
NCT03460002 · 28,612 participants · Start Nov 2016 · Primary completion Oct 2021
Drug: Measles vaccine; Oral polio vaccine · For: Measles Vaccination; Oral Polio Vaccine; Non-specific/Heterologous Effects of Vaccines and 3 more
Sites: Bissau, Guinea-Bissau
Sanofi Pasteur, a Sanofi CompanySanofi (SNY)
NCT00855855 · 20,830 participants · Start Feb 2009 · Primary completion Dec 2014
Drug: DTaP-IPV/Hib · For: Haemophilus Infections; Diphtheria; Tetanus and 2 more
Sites: Albany, California; Martinez, California; San Francisco, California · 59 sites in all
- Influenza Immunization of Children in IndiaPivotal-lookingCompleted
University of Colorado, DenverAcademic, hospital or other
NCT01680679 · 18,163 participants · Start May 2012 · Primary completion May 2014
Drug: Inactivated Trivalent Influenza Vaccine (TIV); Inactivated poliovirus vaccine (IPV), trivalent · For: Influenza
Sites: Ballabgarh, India
- Trial to Compare Two Strains of BCGPivotal-lookingCompleted
Bandim Health ProjectAcademic, hospital or other
NCT04383925 · 16,390 participants · Start May 4, 2020 · Primary completion Oct 30, 2022
Drug: BCG-Japan; BCG-Russia · For: Death, Infant; Morbidity;Infant
Sites: Bissau, Guinea-Bissau
- Efficacy of GSK Biologicals' Candidate Malaria Vaccine 257049 Against Malaria Disease in Infants and Children in AfricaPivotal-lookingCompleted
GlaxoSmithKlineGSK (GSK)
NCT00866619 · 15,459 participants · Start Mar 27, 2009 · Primary completion Mar 1, 2011
Drug: Malaria Vaccine 257049; Meningococcal C Conjugate Vaccine and 3 more · For: Malaria
Sites: Ouagadougou, Burkina Faso; Lambaréné, Gabon; Kintampo, Ghana · 10 sites in all
- Trial to Compare BCG-Bulgaria and BCG-DenmarkPivotal-lookingStatus unknown
Bandim Health ProjectAcademic, hospital or other
NCT05397678 · 15,000 participants (planned) · Start Oct 21, 2022 · Primary completion Jul 2024
Drug: BCG-Denmark; BCG-Bulgaria · For: Death; Neonatal; Death, Infant; Morbidity;Newborn and 2 more
Sites: Bissau, Guinea-Bissau
Newest research
PubMed records naming it or its code names, newest first.
- Safety evaluation of inactivated poliomyelitis vaccine.
Yan D, Yunji L, Jiawei L, et al. · Hum Vaccin Immunother 2026
- Investigating the weak antibody response to vaccination with inactivated polio virus serotype 3 when delivered by microneedle patch.
Gomaa Y, Kolluru C, Lee JW, et al. · J Control Release 2026
- A multi-center, open-labelled, randomized controlled extended phase III non-inferiority clinical trial to evaluate the immunogenicity and tolerability of poliomyelitis vaccine (Vero cells), inactivated, Sabin strains administered with or without routine infant vaccines.
Islam MA, Zehra SM, Kazi Z, et al. · Vaccine 2026
- [Comparison of pertussis incidence trends before and after the COVID-19 pandemic: Investigation of factors behind the surge in pertussis cases in Kanagawa Prefecture (Week 1, 2018 - Week 33, 2025)].
Kimura M, Kaneto C, Ito M, et al. · Nihon Koshu Eisei Zasshi 2026
- Commemorating the Centenary of Fangzhou Gu.
Song Q, Liang Y, Shi J, et al. · China CDC Wkly 2026
- Evaluating the safety profile of poliomyelitis vaccines: insights from post-marketing surveillance.
Qiu G, Ma XD, Fu FF · Virol J 2026
Also in development for Healthy Volunteers
- PPV2323-valent Pneumococcal Polysaccharide Vaccine, lot 1Phase 36 trials
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd · Healthy Volunteers, Streptococcus Pneumoniae Infection, Pneumococcal Disease
- PCV21 vaccinePhase 35 trials
Sanofi · Pneumococcal Immunization, Healthy Volunteers
- TDVTAK-003, Tetravalent Dengue VaccinePhase 35 trials
Takeda · Dengue Fever, Healthy Volunteers
- DTap-HepB-IPV-Hib vaccineHexyon, Infanrix hexaPhase 34 trials
Sanofi · Healthy Volunteers, Meningococcal Immunization, Pneumococcal Immunization
- MenACYW conjugate vaccineNimenrixPhase 34 trials
Sanofi · Healthy Volunteers, Meningococcal Immunisation, Meningococcal Immunization
- HexaximHexaxim Vaccine, DTaP-IPV-Hib-HepB vaccinePhase 32 trials
Sanofi · Pneumococcal Immunization, Meningococcal Immunisation, Healthy Volunteers
- IIV-HDstandalonePhase 32 trials
Sanofi · COVID-19 Immunization, Influenza Immunization, Immunization
- NVXC19EU licensed, standalonePhase 31 trial
Sanofi · Immunization, Healthy Volunteers, COVID-19 Immunization
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.